Expanded programme on immunization

Four Western Pacific countries and areas are the first in their Region to be measles-free

WHO

SEOUL, 20 March 2014 – The World Health Organization Western Pacific Region celebrates a milestone today with the announcement of measles elimination by Australia, Macao (China), Mongolia and the Republic of Korea. They are the first countries or areas in the Region to receive this distinction. Measles kills approximately 330 people worldwide every day, mostly children under the age of five, making this a truly significant achievement as WHO Member States in the Western Pacific Region work towards the elimination of measles.

Inactivated polio vaccine (IPV) tender pricing announced

WHO/F. Guerrero

MANILA, 11 March 2014 – Moving from the oral polio vaccine to an inactivated and injectable polio vaccine (IPV) is crucial to ensure a polio-free world by 2018. According to Global Polio Eradication Initiative's (GPEI) Polio Eradication and Endgame Strategic Plan 2013-2018, the 125 countries still using only trivalent oral polio vaccine (tOPV), 17 of which are in the Western Pacific Region, should introduce at least one dose of inactivated polio vaccine in their immunization schedule by the end of 2015. The price of the inactivated polio vaccine has now been announced.

WHO Western Pacific Region celebrates World Immunization Week, 21-27 April 2014

After a very successful Regional Immunization Week 2013, the countries in the Region are getting ready to observe the Regional Immunization Week 2014 from 21-27 April 2014. The theme for Regional Immunization Week 2014 is "Stop hepatitis B and liver cancer. Vaccinate at birth."

Preventing cervical cancer in Lao People's Democratic Republic

WHO/C. McNab

Lao People’s Democratic Republic, October 2013 - This month, the Lao People’s Democratic Republic introduced the vaccine that helps to prevent cervical cancer.

Each year, more than 270 000 women globally die of cervical cancer, and 85% of these live in low- and middle-income countries. Often, screening for pre-cancerous lesions and cervical cancer treatment are unavailable due to a lack of trained personnel, equipment and affordable therapy.

The vaccine works by preventing infection with the human papillomaviruses (HPV) that cause about 70% of cervical cancers. Due to its high cost, the vaccine has been out of reach in many low- and middle-income countries. But now the GAVI Alliance, with technical support from WHO, is making it available to girls. The Lao People’s Democratic Republic is one of the first countries to launch an HPV vaccine demonstration project.

Contact information

Expanded Programme on Immunization
Regional Office for the Western Pacific
World Health Organization
P.O. Box 2932
1000 Manila
Philippines
Tel. no. (+63 2) 5288001
Fax no. (+63 2) 5211036, 5260279
epi@wpro.who.int